Richest businesswomen in India:
# Roshni Nadar Malhotra is the chairperson of HCL Technologies. She is also the CEO of HCL Corporation, a Trustee of the Shiv Nadar Foundation, and the Founder and Trustee of The Habitats Trust. She is the first richest Indian businesswoman.
Roshni Nadar Malhotra
Since its establishment, the Shiv Nadar Foundation has invested $1.1 billion in nation-building institutions and driving inventive leadership.
She is the Chairperson and driving force behind VidyaGyan, a leadership academy for the economically underprivileged, praiseworthy, rural students of Uttar Pradesh(U.P), and has been working towards raising future leaders from rural India who can be agitators of change for their communities, villages and for the nation.
Falguni Nayar, Founder of Nykaa
#Falguni Nayar, the founder of Nykaa, one of India’s biggest online fashion and lifestyle portals, had been living a luxurious life. She is the second richest businesswoman in India.
After serving 20 years as a venture investor and merchant with Kotak Mahindra, she suddenly announced her decamping to pursue her dream.
Capitalizing on the scope of beauty and skincare products online, she maneuver herself towards Nykaa, and out came a platform that fabricated history with its advent.
Running her online business successfully, along with 35 physical stores, make way for an entrepreneur who told the world that age is just a number. Age didn’t describe the capability of a person.
Kiran Mazumdar Shaw
# Kiran Mazumdar-Shaw is a first-generation entrepreneur and global business leader with over 4 decades of experience in the field of biotechnology.
She is the Executive Chairperson of Biocon Limited and Biocon Biologics Limited. Fueled by her passion, she started her biotech journey in 1978 from her coach station in India.
Today, that journey is changing lives for the better across the globe. She is considered as an unorthodox thinker with many firsts to her credit.
Under her patronage, Biocon delivers on the promise of making medicines accessible and affordable to millions of patients worldwide.
By Nimisha Sharma | On Wed 24 Aug 2022